Association of Systemic Inflammatory Response Syndrome with Clinical Outcomes of Pediatric Patients with Pneumonia

Steven Barron Frazier1, Robert Sepanski1, Christopher Mangum1

  • 1From the Department of Pediatrics, Children's Hospital of the King's Daughters/Eastern Virginia Medical School, Norfolk.

Southern Medical Journal
|November 6, 2015
PubMed

Insights

Systemic inflammatory response syndrome (SIRS) in children with pneumonia indicates more severe illness. Identifying SIRS in the emergency department can help pinpoint children needing closer monitoring and advanced treatment for better outcomes.

Area of Science:

  • Pediatric Emergency Medicine
  • Critical Care
  • Infectious Diseases

Background:

  • Systemic inflammatory response syndrome (SIRS) is a potential complication of pneumonia in children.
  • The presence of SIRS suggests increased pneumonia severity and may warrant closer clinical evaluation.
  • Early identification of SIRS in pediatric pneumonia patients is crucial for timely intervention.

Purpose of the Study:

  • To investigate the association between SIRS and adverse clinical outcomes in children with community-acquired pneumonia.
  • To evaluate the utility of SIRS as an indicator for identifying high-risk pediatric pneumonia patients in the emergency department.

Main Methods:

  • Retrospective chart review of 276 children diagnosed with community-acquired pneumonia in a pediatric emergency department.
  • SIRS criteria adapted from the International Consensus Conference on Pediatric Sepsis, considering age-adjusted vital signs and white blood cell counts.
  • Morbidity endpoints included hospital admission, ED return, need for surgery, mechanical ventilation, and length of hospital stay.

Main Results:

  • Children with SIRS (n=38) showed significantly higher rates of hospital admission or ED return (79% vs. 34.5%) compared to SIRS-negative patients (n=238).
  • SIRS-positive pediatric pneumonia patients had a greater risk of requiring video-assisted thoracoscopic surgery (18.4% vs. 0.8%) and mechanical ventilation (10.5% vs. 0.8%).
  • Median length of hospital stay was substantially longer for children with SIRS (2.7 days vs. 0.19 days).

Conclusions:

  • SIRS in pediatric community-acquired pneumonia is strongly associated with more severe disease and adverse clinical outcomes.
  • Implementing a sepsis screening tool to identify SIRS in pediatric pneumonia patients in the ED can aid in recognizing those needing intensive management.
  • This approach may improve patient stratification and resource allocation for children with severe pneumonia.
Abstract

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.2K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
4.1K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
1.3K
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
38
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
1.5K